"Dr Hill said the ivermectin results were encouraging, but further studies were needed to provide global regulators with evidence robust enough to warrant approvals.
“It’s a generic drug used all over the world. It costs 12 cents to make the drug substance. The drug costs $3 in India, $960 in the US,” Dr Hill told the Financial Times.
The drug could make it harder for people to be infected and it could be harder for those with the disease to infect anyone else, the researchers have posited."